Post-transplant cyclophosphamide after matched sibling, unrelated and haploidentical donor transplants in patients with acute myeloid leukemia: a comparative study of the ALWP EBMT
Mohamad Mohty(Inserm), Luca Castagna(Humanitas University), Didier Blaise(Institut Paoli-Calmettes), Fabio Ciceri(San Antonio College), Boris V. Afanasyev(First Pavlov State Medical University of St. Petersburg), Jaime Sanz(Memorial Sloan Kettering Cancer Center), Myriam Labopin(Sorbonne Université), José L. Díez‐Martín(Universidad Complutense de Madrid), Arnon Nagler(Tel Aviv University), Jan J. Cornelissen(Amsterdam UMC Location University of Amsterdam), Jacques‐Emmanuel Galimard(Hôpital Saint-Antoine), Emanuele Angelucci(Ospedale Policlinico San Martino), Annalisa Ruggeri(Inserm), Yener Koç(Antalya IVF), Bipin N. Savani(Vanderbilt University Medical Center), Ellen Meijer(Hospital General Universitario Gregorio Marañón), Montserrat Rovira(Humanitas University)
Cited by 117
Related Papers
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency
|New England Journal of Medicine|2009|1k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859